CNBC Pro

Jefferies upgrades Tilray to buy, says pot stock can soar more than 60%

A security guard stands in a greenhouse of Tilray medical cannabis producer's European production site in Cantanhede, on April 24, 2018.
Patricia De Melo Moreira | AFP | Getty Images

The merger between cannabis companies Aphria and Tilray officially closed this week, and the resulting company is set up to be a major player in multiple countries as legal weed gains strength, according to Jefferies.

Analyst Owen Bennett upgraded Tilray on Friday to buy from underperform, saying in a note to clients that the strengths of the two companies complement one another and position the new company for success in Europe and North America.

More In Street Calls

Here are Tuesday's biggest analyst calls: Apple, Amazon, Tesla, Disney, Roku, Boeing, UPS & more
CNBC ProHere are Tuesday's biggest analyst calls: Apple, Amazon, Tesla, Disney, Roku, Boeing, UPS & more
Tesla's valuation is looking more reasonable, but stock still isn't a buy, Bernstein says
CNBC ProTesla's valuation is looking more reasonable, but stock still isn't a buy, Bernstein says
Jefferies downgrades Generac, cites rising competition from 'game-changing' technology
CNBC ProJefferies downgrades Generac, cites rising competition from 'game-changing' technology